Global Drug Delivery Partnering Terms and Agreements 2016 - 2023


The Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

Publication date
May 2023
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

The Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.


This report provides details of the latest drug delivery agreements announced in the life sciences since 2016.


The report takes the reader through a comprehensive review drug delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering drug delivery partnering deals.


The report presents financial deal term values for drug delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the drug delivery partnering field; both the leading deal values and most active drug delivery dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 1,500 online deal records of actual drug delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of drug delivery dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in drug delivery dealmaking since 2016, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading drug delivery deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 25 most active companies in drug delivery dealmaking with a brief summary followed by a comprehensive listing of drug delivery deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of drug delivery partnering deals signed and announced since Jan 2016, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of drug delivery partnering deals signed and announced since Jan 2016. The chapter is organized by specific drug delivery technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by drug delivery partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in drug delivery partnering and dealmaking since 2016.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of drug delivery technologies and products.


Key benefits


Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 provides the reader with the following key benefits:


  • In-depth understanding of drug delivery deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual drug delivery contracts entered into by leading biopharma companies
  • Identify most active drug delivery dealmakers since 2016
  • Insight into terms included in a drug delivery partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 is intended to provide the reader with an in-depth understanding and access to drug delivery trends and structure of deals entered into by leading companies worldwide.


Drug Delivery Partnering Terms and Agreements includes:


  • Trends in drug delivery dealmaking in the biopharma industry since 2016
  • Access to headline, upfront, milestone and royalty data
  • Access to drug delivery contract documents
  • Leading drug delivery deals by value since 2016
  • Most active drug delivery dealmakers since 2016


In Global Drug Delivery Partnering Terms and Agreements 2016 - 2023, the available deals are listed by:


  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 report provides comprehensive access to available deals and contract documents for over 1,500 drug delivery deals.


Analyzing actual contract agreements allows assessment of the following:


  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Drug Delivery Partnering Terms and Agreements 2016 - 2023 provides the reader with the following key benefits:


  • In-depth understanding of drug delivery deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual drug delivery contracts entered into by leading biopharma companies
  • Identify most active drug delivery dealmakers since 2016
  • Insight into terms included in a drug delivery partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in drug delivery dealmaking


2.1. Introduction

2.2. Drug delivery partnering over the years

2.3. Most active drug delivery dealmakers

2.4. Drug delivery partnering by deal type

2.5. Drug delivery partnering by therapy area

2.6. Deal terms for drug delivery partnering

      2.6.1 Drug delivery partnering headline values

      2.6.2 Drug delivery deal upfront payments

      2.6.3 Drug delivery deal milestone payments

      2.6.4 Drug delivery royalty rates


Chapter 3 – Leading drug delivery deals


3.1. Introduction

3.2. Top drug delivery deals by value


Chapter 4 – Most active drug delivery dealmakers


4.1. Introduction

4.2. Most active drug delivery dealmakers

4.3. Most active drug delivery partnering company profiles


Chapter 5 – Drug delivery contracts dealmaking directory


5.1. Introduction

5.2. Drug delivery contracts dealmaking directory


Chapter 6 – Drug delivery dealmaking by technology type





Appendix 1 – Drug delivery deals by company A-Z


Appendix 2 – Drug delivery deals by stage of development




Phase I

Phase II

Phase III





Appendix 3 – Drug delivery deals by deal type


Asset purchase


Bigpharma outlicensing


Collaborative R&D







Equity purchase



Joint venture





Material transfer





Spin out



Technology transfer




Appendix 4 – Drug delivery deals by therapy area


Appendix 5 – Deal type definitions


Appendix 6 – Further reading on dealmaking


About Wildwood Ventures


Current Partnering

Current Agreements

Recent report titles from Current Partnering


Table of figures


Figure 1: Drug delivery partnering since 2016

Figure 2: Active drug delivery dealmaking activity since 2016

Figure 3: Drug delivery partnering by deal type since 2016

Figure 4: Drug delivery partnering by disease type since 2016

Figure 5: Drug delivery deals with a headline value

Figure 6: Drug delivery deals with an upfront value

Figure 7: Drug delivery deals with a milestone value

Figure 8: Drug delivery deals with a royalty rate value

Figure 9: Top drug delivery deals by value since 2016

Figure 10: Most active drug delivery dealmakers since 2016


Pricing options

  • $3,995: single-user
  • $5,745: multi-user
  • $10,995: single site license
  • $17,995: global site license


A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3 Rivers Biotech, 3DMed, 3P Biopharmaceuticals, 3SBio, A*STAR Agency for Science, Technology and Research, A1 Group, Abbott Laboratories, Abbvie, Abcam, ABL Bio, Abnova, Absorption Systems, ABVC BioPharma, Acacia Pharma, Accord Healthcare, Accuredit Therapeutics, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acer Therapeutics, Acerus, Ache, Aclaris Therapeutics, Acorda Therapeutics, Actavis (acquired by Watson), Actelion, AcuCort, Acuitas Therapeutics, Acuity Pharmaceuticals, Aculys Pharma, Acura Pharmaceuticals, AdAlta, Adama, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adaptive Health, Adapt Pharma, Adare Pharma Solutions, Adhera Therapeutics, Adhesys Medical, Adhex Pharma, Adhezion Biomedical, Admedus, Advanced Catheter Therapies, Advanced Medical Solutions, Advaxis, Adverum Biotechnologies, Aegis Therapeutics, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aeromics, AeroRx Therapeutics, Afaxys Pharmaceuticals, Affilogic, AFT Pharmaceuticals, AFYX Therapeutics, Aggrega Pharma, Agile Therapeutics, Aguettant, AIM ImmunoTech, AimMax Therapeutics, Ainos, Aires Pharmaceuticals, AIT Therapeutics, Ajax Therapeutics, Akari Therapeutics, Akorn, Albany Molecular Research, Albumedix, Alcon Laboratories, Alcove Manufacturing and Distribution, Alcyone Lifesciences, Alcyone Therapeutics, Alessa Therapeutics, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfa Wassermann, Alimera Sciences, ALK-Abello, Allegis Pharmaceuticals, Allergan, Alliance for Lupus Research, Alliance Pharma, AllianceRx Walgreens Prime, Allied Corp, Allogene Therapeutics, AlloSource, Ally Biotech, Almirall, Alnylam Pharmaceuticals, Alphamab Biopharmaceuticals, ALRISE Biosystems, ALS Association, Altamira Therapeutics, Altasciences, Alteogen, Altimmune, Altum Pharmaceuticals, Altus Formulation, Aluna, Alvit LCS Pharma, Alzamend Neuro, Alzyn, Amag Pharmaceuticals, Amarantus BioSciences, Ambiopharm, Amedica, American Diabetes Association, American Renal Associates, Amerigen Pharmaceuticals, Amgen, AMI, Amneal Pharmaceuticals, AMPEL BioSolutions, AMSL, Amunix, ANANDA Scientific, Andau Medical, Andor Pharmaceuticals, Andros Pharmaceuticals, Angelini Pharma, AnGes MG, Anika Therapeutics, ANI Pharmaceuticals, Anji Pharma, Anova Enterprises, Antares Pharma, Apellis Pharmaceuticals, Apex Ridge Consulting, Apexus, Aphria, ApiJect Systems, Aposense, AppianRx, Applied DNA Sciences, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apsen Farmacutica, AptarGroup, Aptar Pharma, Aquavit Pharmaceuticals, Aquestive Therapeutics, Aralez Pharmaceuticals, Arbor Biotechnologies, Arbutus, Arcoral Pharma, Arctic Vision, Arecor, Areva Med, Argentum Pharmaceuticals, argenx, Aries Pharmaceuticals, Arla Foods, Armas Pharmaceuticals, ARS Pharmaceuticals, Artios Pharma, Art of Technology, ARWAN Pharmaceuticals, Asahi Kasei, Asahi Kasei Kuraray Medica, Ascendia Pharmaceuticals, Ascend Therapeutics, Ascensia Diabetes Care, Ashland, Asieris MediTech, Asklepios Biopharmaceutical, Aspargo Laboratories, Aspen Global, Aspen Pharmacare Canada, Assertio Therapeutics, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma Europe, AstraZeneca, ATAI Life Sciences, Athenex, Atossa Therapeutics, Attralus, ATUM, Aucta Pharmaceuticals, Aura Biosciences, AuraVax Therapeutics, Auris Medical, Aurora Cannabis, AusHealth, Autotelic, Auxly Cannabis Group, Avacta, Avance Clinical, Avanos Medical, Avara Pharmaceutical Services, AV Cannabis, Avectas, Avellino Labs, Avenue Therapeutics, AviadoBio, Avidea Technologies, Avior Bio, Aviragen Therapeutics, AVIR Pharma, Avita Therapeutics, AXIM Biotechnologies, Aytu BioPharma, AzurRx BioPharma, Bausch & Lomb, Bausch Health Companies, Baxter International, Bayer, Bazelet, Bazis NN, B Braun, BDD Pharma, Beam Therapeutics, Bebig, Becton Dickinson, Beijing Keyuan Xinhai Pharma, Ben-Gurion University, Berkshire Biomedical, Besins Healthcare, Bespak, Best Choice, Betaliq, BetterLife Pharma, BevCanna, Bexson Biomedical, Beyond Air, BGN Technologies, Bhami Research, Bharat Biotech, Bial, Bigfoot Biomedical, Bill and Melinda Gates Foundation, BIND Therapeutics, Binex, Bio-Techne, Bio-Thera Solutions, Bioarc, BioArctic Neuroscience, biOasis Technologies, BioAxone BioSciences, Biobot Surgical, BioCardia, Biocomposites, BIOCORP, BioCorRx, Biodelivery Sciences, Bio DG, Biogen, Biohaven Pharmaceuticals, BioKey, Biolinear Technologies, BioLingus, Biological E, Biologix FZCo, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, BiomX, Bionaut Labs, BioNTech, BioNxt Solutions, Biophage Pharma, Biopharmaceutical Research Company, BiopharmX, BioQ Pharma, BioRAE, Biorchestra, Biosensors International, BioSig Technologies, Bioventus, BioXcel, Birdie Biopharmaceuticals, Blackstone, BLP Management, BlueRock Therapeutics, BlueWillow Biologics, BMG Pharmaceuticals, BNC Korea, Boehringer Ingelheim, Bora Pharmaceuticals, Boston Topicals, Bpifrance, Braeburn Pharmaceuticals, Breath of Life International, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, BridgeBio Pharma, Bridge Medicines, Brigham and Women's Hospital, BrightFocus Foundation, Brill Pharma, Bristol-Myers Squibb, BRNT, Bryn Pharma, C-Tri, Cadila Pharmaceuticals, Calidi Biotherapeutics, California Institute for Biomedical Research, Calyptus Pharmaceuticals, Camargo Pharmaceutical Services, Camarus, Cambridge Healthcare Innovations, CamDiab, Cam Med, Camurus, Canada-Israel Industrial R&D Foundation, Cancer Prevention and Research Institute of Texas, Candela, Candel Therapeutics, Cannabics Pharmaceuticals, CannaKids, Cannaponics, CannaRoyalty, CannaSkin, Cannassure Therapeutics, Cannatrek Medical, CanniMed Therapeutics, CannPal Animal Therapeutics, CannRx Technology, Canntab Therapeutics, Canopy Growth, CanSinoBIO, Cantabria Pharma, Capcium, Capillary Biomedical, Capna Intellectual, Cara Therapeutics, Caravan Biologix, Cardinal Health, Cardiome Pharma, Cardiovascular Systems, CareTaker Medical, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, Carnegie Mellon University, CarThera, CASI Pharmaceuticals, Cassiopea, Catalent, CBDerma Technology, CBD Supply MD, CBx Data Labs, CC Biotechnology, Ceapro, Cedars-Sinai Medical Center, Celanese, Celator, Celgene, Cella Therapeutics, Cell Care Therapeutics, Cellectar Biosciences, Celling Biosciences, Cellix Bio, CellProThera, Cell Signaling Technology, Cell Therapy Manufacturing Center, Celltrion, Celularity, Centers for Disease Control and Prevention, Central Admixture Pharmacy Services, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Human Drug Research, Centro de Investigación Biomédica en Red de Salud Mental, Cequr, Cerenis Therapeutics, Chansu Vascular Technologies, Charles River Laboratories, Chemesis, ChemoMouthpiece, ChemWerth, Cheplapharm Arzneimittel, Chiesi Farmaceutici, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's National Medical Center, China Grand Pharmaceutical, China Medical System, China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Sciences, Chiome Bioscience, Chugai Pharmaceutical, CicloMed, Cingulate, Cipher Pharmaceuticals, Cipla, Circassia, Citius Pharmaceuticals, Citrine Medicine, Civica Rx, Clear Guide Medical, ClearPoint Neuro, Clearside Biomedical, Cleveland Diabetes Care, Cleveland University Hospitals, Clinical Trial and Consulting Services, CliniFusion, Clinigen, CloudCath, CMIC, CMS Aesthetics, CMS Medical, CMT Research Foundation, Coalition for Epidemic Preparedness Innovations, Cocoon Biotech, Codiak BioSciences, Collegium Pharmaceuticals, Colorcon, Columbia Care, Columbia University, CombiGene, CoMedical, Comera Life Sciences, Common Sensing, Companion Medical, Complix, Consegna Pharma, ConserV Bioscience, Consilient Health, Consort Medical, Context Therapeutics, ConvaTec, Cook Biotech, Cooper Surgical, COPD Foundation, Corium International, CorMedix, Cornerstone Animal Health, Corning, Coronado Biosciences, Corsair Pharma, Cortigent, CorVascular, Corvida Medical, Cosmo Pharmaceuticals, Cove, Covis Pharmaceutical, Coya Therapeutics, Credence MedSystems, Crescita Therapeutics, CRISPR Therapeutics, Cristal Therapeutics, Crohn's and Colitis Foundation of America, CROMA Pharma, Cronos Group, Crown Laboratories, CR Pharma, CrystecPharma, CSIRO, CSL Behring, CS Pharmaceuticals, CTT Pharmaceutical, CTX Technology, Cumberland Pharmaceuticals, Curadigm, CURE Pharmaceutical, Currax Pharmaceuticals, Cutanea Life Sciences, Cutia Therapeutics, CVS Caremark, CV Sciences, Cybin, Cycle Pharmaceuticals, Cyclolab, Cyclo Therapeutics, Cyndea Pharma, Cynosure, Cyrano Therapeutics, Cystic Fibrosis Foundation, Cystic Fibrosis Trust, D&D Pharmatech, D. Western Therapeutics Institute, Daewoong Pharmaceutical, Daiichi Sankyo, Dalhousie University, Dance Biopharm, Danish Innovation Fund, Dare Bioscience, DarioHealth, DBV Technologies, Dechra Pharmaceuticals, Decibel Therapeutics, Defense Advanced Research Projects Agency, Defense Health Agency (US), Defense Threat Reduction Agency, Defymed, DEKA Research and Development, Delcath Systems, Delivra, Delpor, DelSiTech, Delta 9 Cannabis, Denali Therapeutics, Department of Defense, DepoMed, Dermira, Desert Medical Campus, DexCom, Diabeloop, Diomics, DisperSol Technologies, Diurnal, Dixie State University, DKSH, Dorizoe Lifesciences, Dosecann, DOSE Medical, Dow Chemical, Dr. Reddy's Laboratories, Dr Bragi Company, Dr Kerklaan Therapeutics, DS Biopharma, Durect, Dynasil, Dyve Biosciences, Eagle Pharmaceuticals, Eastman Chemical Company, ECM Medical, ECM Therapeutics, Edenbridge Pharmaceuticals, Edge Pharma, Editas Medicine, EffRx, Egalet, EG Gilero, Egis, Ei.Ventures, EirGen Pharma, Eirion Therapeutics, Eisai, Eitan Group, Elasmogen, Elcelyx Therapeutics, Elektrofi, Eleven Biotherapeutics, Eli Lilly, Elite Pharmaceuticals, Elute, EMC, eMed, Emerald Health Therapeutics, Emerge Health, Emergent BioSolutions, Emery Pharma, Emmaus Life Sciences, Empower Clinics, Emtora Biosciences, Enable Injections, Enalare Therapeutics, ENA Respiratory, Encore Medical, Endo International, Endo Ventures, Enesi Pharma, enGene, Ennaid Therapeutics, Ensemble Therapeutics, Entegra Laboratories, Enteris Biopharma, Enterprise Therapeutics, Entos Pharmaceuticals, Entrada Therapeutics, Enveric Biosciences, Envisia Therapeutics, Enzymatica, EOFlow, EPI Health, EpiPharma, EsoCap, Espero Biopharma, Esperovax, Esteve, eTheRNA immunotherapies, Ethicon Endo-Surgery, Ethris, Ethypharm, Eton Pharmaceuticals, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eurofarma, European Union, European Union Regional Development Fund, EUSA Pharma, Eve & Co, Everads Therapy, Evero Health, Eversana, Evestra, Evofem, Evoke Pharma, Evonik Industries, Evox Therapeutics, Exact Therapeutics, Exactus, Exela Pharma Sciences, Exeltis, Exonate, Exopharm, ExxPharma Therapeutics, EyeCRO, Eyeganics, Eyegate Pharmaceuticals, Eyenovia, EyePoint Pharmaceuticals, Eyevance, F&M Feed, Fabre Kramer Pharmaceuticals, Factoria Bogar, Fagron, FairJourney Biologics, Famy Life Sciences, Fareva Holding, Farmalider, Feldan Therapeutics, Felix Biotechnology, Ferndale Pharma Group, Ferrer International, Ferring Pharmaceuticals, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., First Wave Bio, Flexion Therapeutics, Flower One, Fluidda, Fluid Pharma, Fluum, Flynn Pharma, Foamix Pharmaceuticals, Food and Drug Administration (FDA), ForDoz Pharma, Foresee Pharmaceuticals, Formac Pharmaceuticals, Formosa Pharmaceuticals, Fortify Therapeutics, Four 20 Pharma, Fred Hutchinson Cancer Research Center, Fresenius Kabi Pharmaceuticals, FSD Pharma, Futura Medical, G&W Laboratories, Gad Medical Equipment, Gaeta Therapeutics, Galen, Galvani Bioelectronics, Gardia Medical, GB Sciences, GC Pharma, Gebro Pharma, GE Healthcare, Genco Sciences, GenEdit, Genentech, GeneQuine Biotherapeutics, Genesis MedTech, Genetic Immunity, Genevant Sciences, Genexine, Genisphere, Genpharm, Gensaic, GenScience Pharmaceuticals, Genuv, Geo-Med, Geocann, Georgetown University, Georgia Tech Research Corporation, GeoVax, Gerresheimer, Ghent University, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, Gland Pharma, Glaukos, GlaxoSmithKline, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Global Drug Development Centre (GDCC) China, Globe Med Tech, Glooko, Graviton Bioscience, Green Cross LabCell, Greene Street Pharmaceuticals, Grenco Science, Grifols, Grunenthal, GSW Creative Corporation Canada, Guerbet, GVK Biosciences, GW Pharmaceuticals, Gyroscope Therapeutics, H2-Pharma, Haisco Pharmaceutical, Halodine, Halo Labs, Halo Pharmaceutical, Halozyme Therapeutics, Hangzhou Chance Pharmaceuticals, Harm Reduction Therapeutics, Harrow Health, Harvard University, Haselmeier, HCA Healthcare, HCmed Innovations, HDT Bio, Healix, Health2Sync, Health Canada, Healthcare Royalty Partners, Healthy Directions, HEC Pharm, Heidelberg Pharma, Helix BioPharma, Helsinn Healthcare, Herantis, Heritage Pharmaceuticals, Heron Therapeutics, Heumann Pharma Generics, Hibernation Therapeutics, Higgs Boson Health, High12 Brands, Highland Therapeutics, Hikma Pharmaceuticals, Hill Dermaceuticals, Hillstream BioPharma, HLH BioPharma Vertriebs, HLS Therapeutics, Hoffmann La Roche, Hofseth BioCare, Hollister Biosciences, Hologic, Honeywell, Hookipa Pharma, Horizon Europe, Horizon Pharma plc, Horizon Therapeutics, Horus Pharma, Hospital for Special Surgery, Hoth Therapeutics, Hovione, Huons, Hyloris Pharmaceuticals, Hyphens, Hyundai Pharmaceutical, I-MED Pharma, i2c Pharmaceutical Services, i2O Therapeutics, IACTA Pharmaceuticals, ICAN, iCAN:Israel-Cannabis, ICB Pharma, Ice + Jam, iCeutica, Ichor Medical Systems, Iconovo, Idorsia, iECURE, IGEA Clinical Biophysics, Ilera Holistic Healthcare, ImaginAb, Imbrium Therapeutics, Immune System Regulation, ImmunGene, ImmunoForge, Immunomic Therapeutics, Immunovaccine, Impel NeuroPharma, Imperial Brands, Imperial College London, Impression Healthcare, Imprimis Pharmaceuticals, ImprimisRx, Imunon, Incannex Healthcare, Inceptua, InCube Labs, Incyte, Indee Labs, Indegene Lifesystems, Indivior, Inexia, Infectious Disease Research Institute (IDRI), Inflammasome Therapeutics, InfusAID, Infuseon Therapeutics, InfuSystem Holdings, InfuTronix Solutions, iNGENu, Inhalation Sciences, Inhalon Biopharma, Inhibrx, InMed Pharmaceuticals, InnarisBio, InnoPharmax, Innovare, Innovate UK, Innovation Pharmaceuticals, Innovus Pharmaceuticals, Inolife Technologies, Inovio, Inovio Pharmaceuticals, Inserm, InsightRX, InSitu Biologics, Insmed Inc, Inspira Pharmaceuticals, Inspirevax, Inspirion delivery Sciences, Instillo, Instituto de Biologia Experimental e Tecnológica, Instituto de Ciencias Farmaceuticas, Institut Pasteur, Insulet, InsuLine Medical, Insys Therapeutics, INTACT Solutions, Intarcia Therapeutics, Intas Pharmaceuticals, Intec Pharma, Integra LifeSciences, Integral Molecular, Integrated Medical Systems, IntelGenx, Intellia Therapeutics, Intellipharmaceutics, International Vaccine Institute (IVI), Intract Pharma, Intralytix, Intratus, Intravacc, Inventia Healthcare, InvisiShield Technologies, InVixa, Ionis Pharmaceuticals, Ipsen, IQVIA, IriSys, Iroko Pharmaceuticals, iSage Rx, Isosceles Pharmaceuticals, Israeli National Authority for Technological Innovation, iSTAR Medical, Italfarmaco, iTeos Therapeutics, Itrom Pharmaceutical Group, iVeena delivery Systems, Ivenix, Iveric Bio, ivWatch, iX Biopharma, Jacksonville Pharmaceuticals, Jaeb Center for Health Research Foundation, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Tobacco, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jiangsu Aosaikang Pharmaceutical, Jiangsu NHWA Pharmaceutical, Jiangsu Tainuo, Ji Xing Pharmaceuticals, Johns Hopkins University, JOS Pharmaceuticals, Jounce Therapeutics, Journey Medical, JSC Pharmadis, JT Pharmaceuticals, Jubilant Hollisterstier, Julphar, Juniper Pharmaceuticals, Jupiter Orphan Therapeutics, Juvenile Diabetes Research Foundation, Juyou Biotechnology, K2M, Kaleo, Kali Care, Kalos Therapeutics, Kalytera Therapeutics, Kamada, Kanabo Research, Kancera, Kaneka, Karolinska Institute, Kastle Therapeutics, KBI BioPharma, KC Pharmaceuticals, KemPharm, Kensington Pharma, Kibur Medical, Kimberly-Clark, Kindeva Drug delivery, Kindred Bio, Kings College London, Kira Pharmaceuticals, Klaria, Knight Therapeutics, Konica Minolta, Korea Advanced Institute of Science and Technology, Koru Medical Systems, Kuhnil Pharmaceuticals, Kurve Technology, KVK-Tech, Kyorin Pharmaceutical, Kyowa Hakko Kirin, L-3 Communications, Laboratoires Thea, Laccure, Laevoroc Oncology, Lannett, Lantheus Holding, Lauren Sciences, Lawley Pharmaceuticals, Lawrence Livermore National Laboratory, Leads Biolabs, Lee's Pharmaceutical, Lee Moffitt Cancer Center, Leidos, Leiters, LeMaitre Vascular, Leon-nanodrugs, Leona M and Harry B Helmsley Charitable Trust, LEO Pharma, Leukocare, Lexaria Bioscience, Leyden Laboratories, LianBio, LIDDS, Life Magnetics, Lifestyle delivery Systems, Ligandal, Ligand Pharmaceuticals, Lightlake Therapeutics, Lineage Cell Therapeutics, Link Health, LIPAC Oncology, Lipidor, Lipocine, LipoCure, LipoMedics, Lipomedix Pharmaceuticals, LipoVac, Livzon Pharmaceutical, Lobsor Pharmaceuticals, Locate Therapeutics, Lonza, Los Altos Pharmaceuticals, Lotus Pharmaceuticals, LTR Medical, LTS Lohmann Therapie-Systeme, Lubrizol, Lucideon, Lumara Health, Lumenis, Luminary Therapeutics, LumiThera, Lumosa Therapeutics, Lunatus, Lundbeck, Lupagen, Lupin, Lupin Pharmaceuticals, Luye Pharma Group, Lyndra Therapeutics, Lyomark Pharma, Lyra Therapeutics, Macquarie University, Magle Chemoswed, MainPointe, Malmo University, MangoGen Pharma, Mannin Research, MannKind Biopharmaceuticals, Mapi Pharma, Maple Leaf Green World, Marathon Asset Management, Marina Biotech, Marinomed Biotechnologie, Marinus Pharmaceuticals, Mark Foundation for Cancer Research, Maruho, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mast Therapeutics, Matinas Biopharma, Mati Therapeutics, Mawson Infrastructure, Maxcyte, Maxima Pharmaceuticals, Mayne Pharma, Mayo Clinic, MBF Therapeutics, MC2 Therapeutics, McMaster University, MD Anderson Cancer Center, MDimune, Medac, Med Alliance, Medherant, MedicaSafe, Medicines360, Medidata Solutions, Medigen Vaccine Biologics, Medigus, Medimetriks, MedImmune, MedinCell, Medinova, MediPharm Labs, Mediq, Medisca, Medison Pharma, Medivant Healthcare, Medlab Clinical, Medline Industries, MedLite ID, Medolife Rx, Medovate, MedPharm, Medsenic, Medspray, Medtronic, Med Trust, Meiji Seika, Memorial Sloan Kettering Cancer Center, Menarini, Menarini Asia-Pacific, Mentholatum Company, MentiNova, Merck and Co, Merck KGaA, Mercury Medical, Meroven, Merrimack Pharmaceuticals, Metagenomi, Meta Healthcare, MetP Pharma, MHC Medical Products, Michael James Enterprises, Microbion, Microdermics, Micro Labs, Micron Biomedical, MigVax, Mikart, Milagro Pharmaceuticals, Milestone Scientific, MilliporeSigma, MIM Software, Mind Medicine, Miravo Healthcare, Mission Pharmacal, Mitsubishi Chemical, Mitsubishi Tanabe Pharma, Moberg Pharma, Mobius Therapeutics, Moderna, Moebius Medical, Molecular Targeting Technologies, Molteni Farmaceutici, Monarch Biosciences, Monash University, MonoSolRx, MoonLake Immunotherapeutics, Morgan Stanley, Mosanna Therapeutics, Movi, MSD, Mundipharma, Mycrodose Therapeutics, Myeloid Therapeutics, Mylan Laboratories, Mylan Pharmaceuticals, Myosana Therapeutics, Myrtelle, N1 Life, Nacuity Pharmaceuticals, Nanexa, Nanite, Nanobiotix, Nanocarry Therapeutics, Nanoform, Nanologica, Nanomerics, NanoPass Technologies, Nanopharm, Nano PharmaSolutions, NanoProteagen, Nanoscope Therapeutics, NanoSmart Pharmaceuticals, NanoSphere Health Sciences, Nanotechnology Characterization Laboratory, NaNotics, Nanotronics Health, NapaJen Pharma, Napoltec Life Sciences, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Eye Institute, National Green Biomed, National Healthcare Services (NHS), National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Medical Products, National Research Council of Canada, National Resilience, National Science Foundation, Navamedic, Navidea Biopharmaceuticals, Navigo Proteins, Nemaura Medical, Nemaura Pharma, NEMUS Bioscience, NeoCura Bio-Medical Technology, NeOnc Technologies, Neos Therapeutics, Nephron Dx, Nephron Pharmaceuticals, Nestle Health Science, NeuCen BioMed, Neumentum, Neuramedy, Neurelis, Neurgain Technologies, Neurimmune Therapeutics, Neurim Pharmaceuticals, Neurochase, NeuroOne, NeuroRx, NeuroVive Pharmaceutical, NeuRx Pharmaceuticals, Nevada Center For Behavioral Health, Nevakar, New Age Nanotech, NewCanna Hub, Newsummit Biopharma, New York State, New York University School of Medicine, Neximmune, Nextage Therapeutics, Nextleaf Solutions, Nextremity Solutions, Nicox, Nicoya, Nightstar Therapeutics, Nirvana Life Sciences, NitricGen, Nitto Denko, NLS Pharmaceutics, Nocion Therapeutics, Nordic Pharma Group, North Star Holdings, Norwegian Research Council, Notable Labs, NovaBay Pharmaceuticals, Novaceutical Sciences, Novaliq, Nova Mentis Life Science, Novan Therapeutics, Novarix, Novartis, Novelion Therapeutics, Noveome Biotherapeutics, Novo Nordisk, NRx Pharmaceuticals, NSW Medical Device Fund, NTC, Nu-med Plus, Nuance Pharma, Nucorion, NuMedii, NurExone Biologic, Nuritas, NutraFuels, Nutriband, NuVasive, Nuvisan Pharma Services, Nuvothera, NYU Grossman School of Medicine for Preclinical and Clinical Research, NZMS, Oakland Health, Oakrum Pharma, OBJ, Ocugen, Ocular Therapeutics, Ocular Therapeutix, Oculis, Ocumension Therapeutics, Ocuphire Pharma, OE Meyer, Ohio State Innovation Foundation, Olympus Medical Systems, Omeq Medical, Omeros, Omnicell, Oncology Pharma, OncoNano Medicine, Onconova Therapeutics, Oncorus, OncoSec Medical, Oncosynergy, Oncotelic, OnDosis, One Drop, ONK Therapeutics, Ono Pharmaceutical, Opiant Pharmaceuticals, OPKO Health, OptiBiotix, Optifye Therapeutics, Optimeos Life Sciences, Optimist Inhaler, OptiNose, Optos, Oragenics, Orapharma, Orbis, Orbit Biomedical, Orchestra BioMed, Orexigen Therapeutics, Orexo, Organogenesis, Orgenesis, Ori Biotech, ORIC Pharmaceuticals, Orion, Orion Biotechnology, Orphan Europe, Orsini Healthcare Specialty Pharmacy, Osivax, Osmotica Pharmaceuticals, Ossianix, OsteoRemedies, Otifex Therapeutics, Otonomy, Otsuka, Ovation Science, Ovensa, Ovid Therapeutics, OWC Pharmaceutical Research, Owen Mumford, Oxygen Plus, Oxyrane UK, Oyster Point Pharma, Pacira Biosciences, Palatin Technologies, Palvella Therapeutics, Panaxia, Pancryos, Pandia Health, Pantherna Therapeutics, PanTher Therapeutics, PANTHERx Specialty Pharmacy, Paragon Care Group, Parent Project Muscular Dystrophy, Parexel, Parker Hannifin, Par Pharmaceutical, Particle Dynamics, Particle Sciences, Patara Pharma, Pathaway, Patheon, Pax Labs, PellePharm, PeptiDream, Peptron, Perennial, Performance Health, Pernix Therapeutics, Perrigo, Pfizer, Pharmaceutical Associates, Pharmaceutics International, PharmaEngine, PharmaIN, PharmaJet, PharmaLynk, Pharmanest, Pharmanovia, Pharma Science, Pharmastrip, Pharmathen, PharmaTher, Pharmatronic, PharmEnable, Pharos Life Corporation, Phasex, Phebra, Pherin Pharmaceuticals, Phil, Phillips-Medisize, Phio Pharmaceuticals, Phosphagenics, Photocure ASA, Physiomics, PIC, Picosun, Piedmont Pharmaceuticals, Pieris Pharmaceuticals, Pierre Fabre, Pierre Fabre Dermatologie, PillTracker, Piramal, Pivot Pharmaceuticals, PixarBio, PlantEXT, Plus Therapeutics, Pneuma Respiratory, Pneuma Systems, Pocono Coated Products, Pohang University Of Science And Technology, Pohl Boskamp, Polyganics, Polypeptide Therapeutic Solutions, Polyrizon, Population Council, Portage Glasgow, Portage Pharmaceuticals, Portal Instruments, Poseida Therapeutics, Praxis, Preceyes, Precisa Medical Instruments, Precise Biometrics, Precision Ocular, Precision Virologics, Premier Inc, Presage Biosciences, Pressure BioSciences, Privo Technologies, ProBioGen, Procaps, Processa Pharmaceuticals, Profusa, Progenity, Prokarium, ProLynx, Promius Pharma, Propella Therapeutics, Propeller Health, Pro Pharmaceuticals, Protalix BioTherapeutics, ProtoKinetix, Proveca, Provepharm, Proveris Scientific, ProvideGx, PROVIREX Genome Editing Therapies, Proximagen Group, Psilera, PsiOxus Therapeutics, pSivida, Psycheceutical Bioscience, Public Health England, Pulmatrix, Pulmodyne, Pulmonomy, Pulmotect, Purdue Pharma, Purdue University, PureTech Health, Purnovate, Pyramid Biosciences, Quad Technologies, Quanta, Quinta-Analytica, Quotient Clinical, QureTech Bio, Radient Technologies, Rafa Pharmaceuticals, Rallybio, Rambam Medical Center, Rani Therapeutics, Ra Pharmaceuticals, Rapid Dose Therapeutics, Recipharm, Reckitt Benckiser, Recordati, Recro Pharma, RedHill Biopharma, ReForm Biologics, Regeneron Pharmaceuticals, RegenLab, Regenxbio, Regis Technologies, ReLeaf Europe, Relief Therapeutics, Renaissance Acquisition Holdings, ReNeuron, Renovacare, Replicel Life Sciences, Rescue Hearing, Respira Technologies, Respira Therapeutics, Respirent Pharmaceuticals, Respironics, Resyca, Revive Therapeutics, Revogenex, Rexahn Pharmaceuticals, Reyon Pharmaceuticals, Rhinomed, Rhoshan Pharmaceuticals, Rhythm Pharmaceuticals, Rimidi, Ripple Therapeutics, Roche, Roivant Sciences, Roswell Park Cancer Institute, Rothman Orthopaedic Institute, Rousselot, RoverMed BioSciences, Royal Philips Electronics, RS BioTherapeutics, Rubedo Life Sciences, Rubin Medical, Rutgers University, Salient Surgical Technologies, Salus Pharma, Samabriva, Samsung Electronics, Samyang Biopharmaceuticals, Sandoz, Sanofi, SaNOtize Research and Development, Sante Laboratories, Santen Pharmaceutical, Saol Therapeutics, Saraya, SarcoMed USA, Sarepta Therapeutics, Sartorius Stedim Biotech, Satio, Sato Pharmaceutical, Satsuma Pharmaceuticals, Savara Pharma, Sawai Pharmaceuticals, Scandinavian Health, Scandion Oncology, Schott, Schreiner Group, Sciarra Laboratories, Sciecure Pharma, Science Foundation Ireland, SciSparc, scPharmaceuticals, Secarna Pharmaceuticals, Sedor Pharmaceuticals, Seelos Therapeutics, Sela Medical, SELLAS Life Sciences Group, SemaThera, Sementis, Senju Pharmaceutical, Sensory Cloud, Seqens, Seqirus, SeraNovo, Sesen Bio, Seurat Therapeutics, SFC Fluidics, Shandong Luoxin Pharma, Shanghai Haohai Biological Technology, Sharps Technology, Shasqi, Shenzhen Smoore Technology, Shilpa Medicare, Shin Nippon Biomedical Laboratories, Shinshu University, Shionogi, Shire Laboratories, Shire Pharmaceuticals, Showa Denko, SIFI (Societa Industria Farmaceutica Italiana), Signum Biosciences, Simcere Pharmaceuticals, Simulations Plus, Sinotherapeutics, SipNose, Sirtex Medical, SiSaf, SiteOne Therapeutics, Skinvisible, Skycare Compounding Labs, SkyePharma, Skyline Vet Pharma, Small Business Innovation Research, SMG Pharmaceuticals, Smiths Medical, SocialDiabetes, Societal CDMO, Soin Neuroscience, Solasia Pharma, Soligenix, Solmic Research, Soluble Biotech, Solural Pharma, SomaServe, Sono-Tek, Sonoma Pharmaceuticals, SonoThera, Sophos Biotech, Sorrel Medical, Sorrento Therapeutics, Sorse Technology, Sosei Heptares, Southwest Research Institute, Spanish National Research Council, Spark Therapeutics, Sparsha, Spaulding Clinical Research, Spear Pharmaceuticals, Spectrum Pharmaceuticals, SpePharm, SpineThera, Spiral Therapeutics, SQ Innovation, SRI International, STADA Arzneimittel, Stanford University, Starboard Medical, Starpharma, Starton Therapeutics, St Elizabeth Healthcare, Sterifarma, Stevanato, Strategic Science and Technologies, Strides Pharma Science, Strm.Bio, Subcuject, Summit Biosciences, Sundial Growers, SunGen, Sunovion Pharmaceuticals, Sun Pharmaceutical, Sunstar Suisse, Suono Bio, Supreme Cannabis, Suzhou NeuPharma, Swedish Research Council, SWK Funding, SymBio Pharmaceuticals, Symvivo, Synairgen, Syntegon, Synthetic Biologics, Synthonics, Syqe Medical, Tabula Rasa HealthCare, Tactical Relief, Taiba, Taisho Pharmaceutical, Taiwan Liposome Company, Takeda Pharmaceutical, TALLC, Tamir Biotechnology, Tandem Diabetes Care, Tanner Pharmaceuticals, Targeted Therapy Technologies, Targetrin Therapeutics, Targovax, Tauriga Sciences, Te Arai BioFarma, TEDOR Pharma, Teewinot Life Sciences, Teikoku Pharma USA, Teligent, Telix Pharmaceuticals, Temple University, Tenacia Biotechnology, TerrAscend, TerSera Therapeutics, Terumo, Tesaro, Tetra Bio-Pharma, Teva Pharmaceutical Industries, Teva Pharmaceuticals USA, TFB & Associates, TFF Pharmaceuticals, TFS Corporation, TGen Drug Development, The Alchemists Kitchen, The Kroger, TheracosBio, Therakine, Theramex, Therapeutics Incorporated, TherapeuticsMD, Therapix Bio, Therapyx, Therios Healthcare, Thermo Fisher Scientific, Third Pole Therapeutics, Thirona Bio, Thomas Jefferson University, Threshold Pharmaceuticals, Thrive Cannabis, Tiba Biotech, Tidepool, Tilray, Tioga Research, Titan Pharmaceuticals, Tiziana Life Sciences, TLC BioSciences, TLC Medical, TONIX Pharmaceuticals, Toray, Torii Pharmaceutical, Toshiba, Towa Pharmaceutical, Transcoject, Transdermal delivery Solutions, Trevi Therapeutics, Triastek, Trigemina, TriReme Medical, TriSalus Life Sciences, Tris Pharma, Tritech, TRPharm, True North Cannabis, TSRL, Tulex Pharmaceuticals, Turing Pharmaceuticals, twoXAR, Tyligand Bioscience, TypeZero Technologies, Ubiquigent, UCB, Uluru, Umoja Biopharma, Unilife, UNION Therapeutics, UniQuest, United Nations Children Fund, United Therapeutics, Univar, Universidad de Cadiz, Universidad De Sevilla, Universidad de Seville, University of Alabama at Birmingham, University of Antwerp, University of California, Davis, University of Cologne, University of Colorado, University of Connecticut, University of Edinburgh, University of Geneva, University of Georgia, University of Glasgow, University of Houston, University of Iowa, University of Leipzig, University of Liverpool, University of Maryland, University of Minnesota, University of Missouri, University of Nebraska, University of New South Wales, University of North Texas, University of Notre of Dame, University of Nottingham, University of Oxford, University of Pennsylvania, University of Pittsburg, University of Pittsburgh, University of Prince Edward Island, University of Queensland, University of Sheffield, University of Sydney, University of Tennessee, University of Texas, University of Utah, University of Virginia, University of Wisconsin-Madison, Upadia, Uppsalagruppen Medical, Upsher-Smith, UroGen Pharma, Ursapharm, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Biologic, US Bioservices, US Government, Utrecht University, Vaccibody, Valeant Pharmaceuticals, Valens Company, Valeo Pharma, Valeritas, Vapium, Vaxart, Vaxess Technologies, V ClinBio, Vect-Horus, Vector BioPharma, Vectura, Veeva Systems, VerdePharmHealth, Verily, Verndari, Verrica Pharmaceuticals, Verve Therapeutics, Vesselon, Vetter, ViaCyte, Vical, Vigene Biosciences, ViiV Healthcare, Vinnova, ViralClear Pharmaceuticals, Virpax Pharmaceuticals, VisionCare Ophthalmic Technologies, VistaGen Therapeutics, Visus Therapeutics, Vitanova Biomedical, Vitruvias Therapeutics, VivaCell Biotechnology Espana, Vivani Medical, Vivasc Therapeutics, Vivera Pharmaceuticals, Vizient, Voronoi, Voyager Therapeutics, Vyera Pharmaceuticals, Vygon, VYNE Therapeutics, W.R.Grace, Wageningen University, Wakamoto Pharmaceutical, Walter Reed Army Institute of Research, Washington University in St Louis, Watson Laboratories, Welding, WellDoc, Wellesta, Wellman Center For Photomedicine, Werewolf Therapeutics, West Pharmaceutical Services, Windgap Medical, Winhealth Pharma Group, W L Gore, World Health Organization, Worldwide Clinical Trials, WuXi Biologics, Wuxi STA, Wyss Institute, Xanadu Bio, Xbrane Bioscience, Xcede Technologies, Xellia Pharmaceuticals, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xisle Pharma Ventures Trust, XL-Protein, Yale University, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, Yom Chai, Ypsomed, Zambon, ZappRx, Zealand Pharma, Zenabis, Zerion Pharma, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical, Zhejiang Haichang Biotechnology, Zimmer Biomet, Ziphius Vaccines, Zomedica, Zosano Pharma

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!